Generation Bio (GBIO) on Monday appointed Kevin Conway as chief financial officer and Phillip Samayoa as chief scientific officer.
The company announced the departure of current CFO Matthew Norkunas, effective Friday, and Chief Scientific Officer Matthew Stanton.
Prior to his appointment, Conway was vice president for finance at Generation Bio, while Samayoa served as the company's chief strategy officer.